Serum leptin levels may have diagnostic and predictive roles in patients with pancreatic adenocarcinoma treated with gemcitabine-based chemotherapy.

Karabulut, Senem; AFSAR, Cigdem; KARABULUT, Mehmet; ALIS, Halil; Erturk, Kayhan; Karaman, Şule; KONES, Osman; Bilgin, Elif; Tas, Faruk

Serum leptin levels may have diagnostic and predictive roles in patients with pancreatic adenocarcinoma treated with gemcitabine-based chemotherapy.

Atıf İçin Kopyala

Karabulut S., AFSAR C. U., KARABULUT M., ALIS H., Erturk K., Karaman S., ...Daha Fazla

Journal of B.U.ON. : official journal of the Balkan Union of Oncology, cilt.21, sa.4, ss.895-902, 2016 (SCI-Expanded)

Yayın Türü: Makale / Tam Makale
Cilt numarası: 21 Sayı: 4
Basım Tarihi: 2016
Dergi Adı: Journal of B.U.ON. : official journal of the Balkan Union of Oncology
Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
Sayfa Sayıları: ss.895-902
İstanbul Üniversitesi Adresli: Evet

Özet

Purpose: Leptin is a highly pleiotropic adipokine. Pancreatic adenocarcinoma (PA) and leptin relationship is important. Our aim was to investigate the serum levels of leptin in patients with PA, the relationship of leptin with tumor progression and known prognostic parameters and its diagnostic, predictive and prognostic role.